Pharmaceuticals

Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You

  • by

Scientists and lawmakers agree that over-the-counter covid tests could allow desk workers to settle back into their cubicles and make it easier to reopen schools and travel. This story also ran on Fortune. It can be republished for free. But even as entrepreneurs race their… Read More »Backed by Millions in Public and Private Cash, Rapid Covid Tests Are Coming to Stores Near You

A Plan to Conquer U.S. Drug Shortages

  • by

By JESSICA DALEY and WAYNE RUSSELL COVID-19 has focused the nation’s attention on the risks associated with complex, global supply chains, particularly related to healthcare products and prescription drugs. While supply disruptions of personal protective equipment (PPE) captured headlines, the pandemic also compromised the drug supply chain. With… Read More »A Plan to Conquer U.S. Drug Shortages

In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites

  • by

This story is part of a partnership that includes KPCC, NPR and KHN. It can be republished for free. In California, confusion and botched communication has caused some eligible parents and family caregivers of people with disabilities to be turned away at covid vaccination sites.… Read More »In California, Caregivers of People With Disabilities Are Being Turned Away at COVID Vaccine Sites

Why AstraZeneca and J&J’s Vaccines, In Use the World Over, Are Still on Hold in America

  • by

This story also ran on Fortune. It can be republished for free. The World Health Organization greenlighted emergency use of AstraZeneca and Oxford’s covid-19 vaccine this month, following in the steps of the United Kingdom, the European Union and others, who are already injecting it… Read More »Why AstraZeneca and J&J’s Vaccines, In Use the World Over, Are Still on Hold in America

Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple

  • by

“Pfizer and Moderna could share their design with dozens of other pharma companies who stand ready to produce their vaccines and end the pandemic.” — Feb. 3 in a Facebook post This story was produced in partnership with PolitiFact. It can be republished for free. Vaccine… Read More »Can Pfizer and Moderna End the Pandemic by Sharing Their Vaccine Designs? It’s Not that Simple

States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden

  • by

Florida, Colorado and several New England states are moving ahead with efforts to import prescription drugs from Canada, a politically popular strategy greenlighted last year by President Donald Trump. But it’s unclear whether the Biden administration will proceed with Trump’s plan for states and the… Read More »States Move Ahead With Canada Drug Importation While Awaiting Signal From Biden

KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

  • by

Can’t see the audio player? Click here to listen on SoundCloud. Thursday was “health day” in President Joe Biden’s sprint to launch his presidency, and he signed two executive orders addressing health coverage and women’s reproductive rights. The orders will reopen enrollment under the Affordable Care… Read More »KHN’s ‘What the Health?’: The Long Road to Unwinding Trump Health Policies

Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

  • by

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced “highly significant” news about a drug called remdesivir. That was surprising because the antiviral drug, owned by… Read More »Remdesivir, Given to Half of Hospitalized Covid Patients in U.S., Is Big Win for Gilead — Boosted by Taxpayers

Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid

  • by

Miles de estadounidenses están muriendo a causa de covid-19, pero los esfuerzos para aumentar la producción de vacunas que potencialmente salvan vidas están en un callejón sin salida. Moderna y Pfizer-BioNTech, los fabricantes de las dos vacunas disponibles hasta el momento, están operando al máximo,… Read More »Por qué ni siquiera la presión presidencial podría acelerar las vacunas contra covid

Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?

  • by

Joe Biden ran on an expansive health care platform during his 2020 presidential campaign, with a broad array of promises such as adding a government-sponsored health plan to the Affordable Care Act and lowering prescription drug prices. Perhaps most significantly, he pledged to get control… Read More »Health Issues Carried Weight on the Campaign Trail. What Could Biden Do in His First 100 Days?

Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted

  • by

For Heather Suri, a registered nurse in Virginia, the race to vaccinate Americans against covid has thrown up some unprecedented obstacles. The vaccines themselves are delicate and require a fair bit of focus over time. Consider Moderna’s instructions for preparing its doses: Select the number… Read More »Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted

Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?

  • by

As the rollout of covid-19 vaccines picks up across the U.S., moving from hospital distribution to pharmacies, pop-up sites and drive-thru clinics, health experts say it’s vital that these expanded venues be prepared to handle rare but potentially life-threatening allergic reactions. “You want to be… Read More »Is Your Covid Vaccine Venue Prepared to Handle Rare, Life-Threatening Reactions?

Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy

  • by

The party split in Congress is so slim that, even with Democrats technically in the majority, passing major health care legislation will be extremely difficult. So speculation about President-elect Joe Biden’s health agenda has focused on the things he can accomplish using executive authority. Although… Read More »Biden’s First Order of Business May Be to Undo Trump’s Policies, but It Won’t Be Easy

Single-Cell Sequencing: The New Era of Gene Expression Analysis

  • by

For developing an improved understanding of the interactions of individual cells within their microenvironment, advanced molecular probing solutions are being used by researchers across the globe. In this context, high-throughput single-cell analysis, has emerged as a powerful analytical technique for studying individual cells, enabling researchers… Read More »Single-Cell Sequencing: The New Era of Gene Expression Analysis

Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs

  • by

Health insurance companies will have to give their customers estimated out-of-pocket costs for prescription drugs and disclose to the public the negotiated prices they pay for drugs, under an unexpected new Trump administration rule. The administration said those requirements, part of a broader rule issued… Read More »Surprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs

¿Es hora de discutir los potenciales efectos secundarios de las vacunas para COVID? Científicos dicen que sí

  • by

Se espera que la farmacéutica Pfizer solicite permiso federal para lanzar su vacuna para COVID-19 a fines de noviembre. Una medida que promete acorralar la pandemia, pero que no ofrece mucho tiempo para asegurarse de que los consumidores estén bien informados. Esta vacuna, y probablemente… Read More »¿Es hora de discutir los potenciales efectos secundarios de las vacunas para COVID? Científicos dicen que sí

FDA’s use of real-world data

  • by

The 21st Century Cures Act required the Food and Drug Administration (FDA) establish a program for evaluating the use of real-world data (RWD) to support the approval of new indications for drugs. Real-world data is typically data from either health insurance claims, electronic health records… Read More »FDA’s use of real-world data

As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him

  • by

Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can’t buy this week after President Donald Trump took their experimental drugs for his coronavirus infection, left the hospital and pronounced himself fully recovered. “It was, like, unbelievable. I felt good immediately,” Trump… Read More »As Trump Touts His ‘Great’ COVID Drugs, the Pharma Cash Flows to Biden, Not Him

Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims

  • by

President Donald Trump accepted the Republican Party’s nomination for president in a 70-minute speech from the South Lawn of the White House on Thursday night. Speaking to a friendly crowd that didn’t appear to be observing social distancing conventions, and with few participants wearing masks,… Read More »Republican Convention, Day 4: Fireworks … and Shining a Light on Trump’s Claims